Literature DB >> 30242604

A focus on direct oral anticoagulants: "old" and possible new indications and efforts for a better clinical management.

Domenico Prisco1,2.   

Abstract

Keywords:  Atrial fibrillation; Bleeding; Direct oral anticoagulants; Intracranial hemorrhage; Renal function; Venous thromboembolism

Mesh:

Substances:

Year:  2018        PMID: 30242604     DOI: 10.1007/s11739-018-1954-3

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  20 in total

1.  Variations in clinical management of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation according to different equations for estimating renal function : Post hoc analysis of a prospective cohort.

Authors:  Vincenzo Livio Malavasi; Daniele Pettorelli; Elisa Fantecchi; Cristina Zoccali; Giuliana Laronga; Tommaso Trenti; Gregory Yoke Hong Lip; Giuseppe Boriani
Journal:  Intern Emerg Med       Date:  2018-05-07       Impact factor: 3.397

2.  Management of major bleeding and outcomes in patients treated with direct oral anticoagulants: results from the START-Event registry.

Authors:  Sophie Testa; Walter Ageno; Emilia Antonucci; Rossella Morandini; Jan Beyer-Westendorf; Maurizio Paciaroni; Marc Righini; Piera Sivera; Peter Verhamme; Vittorio Pengo; Daniela Poli; Gualtiero Palareti
Journal:  Intern Emerg Med       Date:  2018-05-22       Impact factor: 3.397

3.  Estimating renal function in patients with atrial fibrillation: which dose of direct oral anticoagulants?

Authors:  Nicoletta Riva; Walter Ageno; Alex Gatt
Journal:  Intern Emerg Med       Date:  2018-05-24       Impact factor: 3.397

4.  Has time come for the use of direct oral anticoagulants in the extended prophylaxis of venous thromboembolism in acutely ill medical patients?

Authors:  Franco Piovella; Diana Irina Iosub
Journal:  Intern Emerg Med       Date:  2018-09-27       Impact factor: 3.397

5.  A clinical conundrum: to measure or not measure direct oral anticoagulants before a surgery or procedure?

Authors:  James D Douketis; Mansoor Radwi
Journal:  Intern Emerg Med       Date:  2018-08-24       Impact factor: 3.397

6.  Intracranial hemorrhage in anticoagulated patients with mild traumatic brain injury: significant differences between direct oral anticoagulants and vitamin K antagonists.

Authors:  Alessandro Cipriano; Alessio Pecori; Alessandra Eugenia Bionda; Michele Bardini; Francesca Frassi; Francesco Leoli; Valentina Lami; Lorenzo Ghiadoni; Massimo Santini
Journal:  Intern Emerg Med       Date:  2018-03-08       Impact factor: 3.397

7.  Multidisciplinary approach to the management of patients with pulmonary embolism and deep vein thrombosis: a consensus on diagnosis, traditional therapy and therapy with rivaroxaban.

Authors:  Davide Imberti; Cecilia Becattini; Enrico Bernardi; Giuseppe Camporese; Claudio Cuccia; Francesco Dentali; Damiano Paretti
Journal:  Intern Emerg Med       Date:  2018-03-08       Impact factor: 3.397

8.  Direct oral anticoagulants: what can we learn?

Authors:  Francesco Marongiu; Doris Barcellona
Journal:  Intern Emerg Med       Date:  2018-03-02       Impact factor: 3.397

Review 9.  Clinical effects with inhibition of multiple coagulative pathways in patients admitted for acute coronary syndrome.

Authors:  Ilaria Cavallari; Giuseppe Patti
Journal:  Intern Emerg Med       Date:  2018-03-21       Impact factor: 3.397

10.  Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients.

Authors:  Alexander T Cohen; Robert A Harrington; Samuel Z Goldhaber; Russell D Hull; Brian L Wiens; Alex Gold; Adrian F Hernandez; C Michael Gibson
Journal:  N Engl J Med       Date:  2016-05-27       Impact factor: 91.245

View more
  2 in total

1.  Direct oral anticoagulants in factor VII deficiency patient.

Authors:  Fulvio Pomero; Laura Spadafora; Salvatore D'Agnano; Francesco Dentali; Luigi Maria Fenoglio
Journal:  Intern Emerg Med       Date:  2019-09-16       Impact factor: 3.397

2.  Is delayed cardioversion the better approach in recent-onset atrial fibrillation? No.

Authors:  Alessandro Capucci; Paolo Compagnucci
Journal:  Intern Emerg Med       Date:  2019-11-13       Impact factor: 3.397

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.